Gsk (GLAXF) Debt Ratio (2016 - 2025)
Gsk has reported Debt Ratio over the past 10 years, most recently at 0.29 for Q4 2025.
- Quarterly results put Debt Ratio at 0.29 for Q4 2025, up 1.67% from a year ago — trailing twelve months through Dec 2025 was 0.08 (up 17.4% YoY), and the annual figure for FY2025 was 0.29, up 1.67%.
- Debt Ratio for Q4 2025 was 0.29 at Gsk, up from 0.29 in the prior quarter.
- Over the last five years, Debt Ratio for GLAXF hit a ceiling of 0.31 in Q4 2023 and a floor of 0.27 in Q4 2021.
- Median Debt Ratio over the past 5 years was 0.29 (2025), compared with a mean of 0.29.
- Biggest five-year swings in Debt Ratio: fell 9.38% in 2021 and later increased 11.79% in 2022.
- Gsk's Debt Ratio stood at 0.27 in 2021, then grew by 11.79% to 0.3 in 2022, then increased by 0.16% to 0.31 in 2023, then fell by 6.59% to 0.29 in 2024, then grew by 1.67% to 0.29 in 2025.
- The last three reported values for Debt Ratio were 0.29 (Q4 2025), 0.29 (Q4 2024), and 0.31 (Q4 2023) per Business Quant data.